BFC Planning’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BFC Planning's TAK Position: Q3 2026 in Review
BFC Planning reduced its Takeda Pharmaceutical (TAK) stake by 84% in Q3 2026, selling an estimated $138K and leaving 1,495 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1872.
BFC Planning first reported a position in TAK in Q3 2024 and has held it in 9 quarters since. The position peaked at $148K in Q2 2026. 343 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- BFC Planning held 1,495 shares of Takeda Pharmaceutical worth $27.2K as of Q3 2026.
- BFC Planning sold 7,766 Takeda Pharmaceutical shares in Q3 2026, an estimated $138K.
- Takeda Pharmaceutical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1872 holding.
- BFC Planning first reported a position in Takeda Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Takeda Pharmaceutical position peaked at $148K in Q2 2026.
- 343 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.